CD4 and metabolic dysfunction-associated steatohepatitis: Together, these studies provide a proteogenomic single-cell atlas for hepatic CD4+ T cells and uncover a CD4+ T cell-dependent immunopathogenic circuit as a promising immunotherapeutic target to alleviate MASH and liver fibrosis.